Literature DB >> 405642

Second malignancies in patients with multiple myeloma.

I P Law, J Blom.   

Abstract

Seven patients with multiple myeloma who developed a second neoplasm are presented. There were four patients with acute leukemia and three patients with non-hematologic neoplasms. The patients with acute leukemia were among the longest survivors (median duration approximately 72 months) and the response to anti-leukemic therapy in these patients was generally poor. Of the three patients with non=hematologic neoplasms, one patient was observed with simultaneous renal cell carcinoma and the other two patients developed adenocarcinoma of the colon and lung subsequently. In addition, two patients with mammary carcinoma who subsequently developed multiple myeloma were included. Literature was reviewed and the possibility that multiple myeloma itself might be a risk factor for the development of other malignancies was discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 405642     DOI: 10.1159/000225175

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  13 in total

1.  Three cases of synchronous solid tumor and multiple myeloma.

Authors:  Sang Hoon Ji; Joon Oh Park; Jeeyun Lee; Mi Jung Oh; Do Hyoung Lim; Byeong-Bae Park; Keun Woo Park; Se-Hoon Lee; Kihyun Kim; Won Seog Kim; Chul Won Jung; Young Suk Park; Young-Hyuck Im; Won Ki Kang; Mark H Lee; Keunchil Park
Journal:  Cancer Res Treat       Date:  2004-10-31       Impact factor: 4.679

2.  Cyclophosphamide in chronic active hepatitis.

Authors:  R Althouse; J E Huff; L Tomatis; J D Wilbourn
Journal:  Br Med J       Date:  1979-06-16

Review 3.  Refractory anaemias.

Authors:  A K Saraya; P S Dhot; R Saxena
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

4.  Myelomatous Pleural Effusion: Case report and review of the literature.

Authors:  Khalil Al-Farsi; Ibrahim Al-Haddabi; Nafla Al-Riyami; Rashid Al-Sukaiti; Salam Al-Kindi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-05-15

Review 5.  Hematologic manifestations of Helicobacter pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

6.  Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer.

Authors:  Spyridon Marinopoulos; Lamprini Skorda; Stylianos Karatapanis; Antonis Rasidakis
Journal:  Med Oncol       Date:  2008-03-15       Impact factor: 3.064

Review 7.  Coexistence of multiple myeloma and clear cell renal cell carcinoma: a case report and review of literature.

Authors:  Gaixiang Xu; Min Yang; Jian Huang; Jie Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

8.  Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics.

Authors:  P Razavi; K A Rand; W Cozen; A Chanan-Khan; S Usmani; S Ailawadhi
Journal:  Blood Cancer J       Date:  2013-06-28       Impact factor: 11.037

9.  Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.

Authors:  Huey-En Tzeng; Cheng-Li Lin; Chun-Hao Tsai; Chih-Hsin Tang; Wen-Li Hwang; Ya-Wen Cheng; Fung-Chang Sung; Chi-Jung Chung
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  Multiple Endocrine Neoplasms in a Patient with AL Amyloidosis-Associated Plasma Cell Dyscrasia.

Authors:  Kunihiko Seki; Shingo Wakatsuki; Kazuo Hizawa; Tadashi Hasegawa; Yuichi Fujinaka; Hiroshi Yokogoshi; Shiro Saito; Toshiaki Sano
Journal:  Endocr Pathol       Date:  1997       Impact factor: 4.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.